Changing clinico-epidemiology of post-kala-azar dermal leishmaniasis (PKDL) in India: Results of a survey in four endemic states
CONCLUSION: PKDL treatment interruption should be reduced through ensuring drug supply and timely retrieval of patients. Directly observed treatment should be implemented and combination regimen should be explored to improve final cure rate. Delivery of financial incentive to PKDL patients and counselling and contraception to women of reproductive age group should be improved.PMID:34290161 | DOI:10.4103/0972-9062.310875
Source: Journal of Vector Borne Diseases - Category: Infectious Diseases Authors: Suman Saurabh Pritam Roy Dhruv K Pandey Dipanjan Ray Shourabh Tarak Rajesh Pandey Dileep Kumar Sarosh Jamil Anand Paulraj Amarendra Kumar Siddhartha Dutta Source Type: research
More News: Dermatology | Endemics | Epidemiology | India Health | Infectious Diseases | Study | Women